|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 2 (January 15), 1999:
pp. 440-446
RAPID COMMUNICATION
Deletion of a Critical Internalization Domain in the G-CSFR in Acute
Myelogenous Leukemia Preceded by Severe Congenital Neutropenia
Melissa G. Hunter and
Belinda R. Avalos
From the Molecular, Cellular, and Developmental Biology Program, Bone
Marrow Transplantation Program, The Ohio State University, Arthur G. James Cancer Hospital and Research Institute, Columbus, OH.
Acquired mutations in the granulocyte colony-stimulating factor
receptor (G-CSFR) occur in a subset of patients with severe congenital
neutropenia (SCN) who develop acute myelogenous leukemia (AML). These
mutations affect one allele and result in hyperproliferative responses
to G-CSF, presumably through a dominant-negative mechanism. Here we
show that a critical domain in the G-CSFR that mediates ligand
internalization is deleted in mutant G-CSFR forms from patients with
SCN/AML. Deletion of this domain results in impaired ligand
internalization, defective receptor downmodulation, and enhanced growth
signaling. These results explain the molecular basis for G-CSFR
mutations in the pathogenesis of the dominant-negative phenotype and
hypersensitivity to G-CSF in SCN/AML.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Sulahian, O. Cleaver, and L. J.-s. Huang
Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia
Blood,
May 21, 2009;
113(21):
5287 - 5297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Germeshausen, M. Ballmaier, and K. Welte
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey
Blood,
January 1, 2007;
109(1):
93 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Rosenberg, B. P. Alter, A. A. Bolyard, M. A. Bonilla, L. A. Boxer, B. Cham, C. Fier, M. Freedman, G. Kannourakis, S. Kinsey, et al.
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy
Blood,
June 15, 2006;
107(12):
4628 - 4635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhuang, Y. Qiu, S. C. Kogan, and F. Dong
Increased CCAAT Enhancer-binding Protein {epsilon} (C/EBP{epsilon}) Expression and Premature Apoptosis in Myeloid Cells Expressing Gfi-1 N382S Mutant Associated with Severe Congenital Neutropenia
J. Biol. Chem.,
April 21, 2006;
281(16):
10745 - 10751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Druhan, J. Ai, P. Massullo, T. Kindwall-Keller, M. A. Ranalli, and B. R. Avalos
Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia
Blood,
January 15, 2005;
105(2):
584 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Walrafen, F. Verdier, Z. Kadri, S. Chretien, C. Lacombe, and P. Mayeux
Both proteasomes and lysosomes degrade the activated erythropoietin receptor
Blood,
January 15, 2005;
105(2):
600 - 608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Hunter, A. Jacob, L. C. O'Donnell, A. Agler, L. J. Druhan, K. M. Coggeshall, and B. R. Avalos
Loss of SHIP and CIS Recruitment to the Granulocyte Colony-Stimulating Factor Receptor Contribute to Hyperproliferative Responses in Severe Congenital Neutropenia/Acute Myelogenous Leukemia
J. Immunol.,
October 15, 2004;
173(8):
5036 - 5045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-J. M. van de Geijn, J. Gits, L. H. J. Aarts, C. Heijmans-Antonissen, and I. P. Touw
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact
Blood,
August 1, 2004;
104(3):
667 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. J. Aarts, O. Roovers, A. C. Ward, and I. P. Touw
Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics
Blood,
January 15, 2004;
103(2):
571 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Doyle, S.-S. Tian, S. G. Miller, L. Kessler, A. E. Baker, M. R. Brigham-Burke, S. B. Dillon, K. J. Duffy, R. M. Keenan, R. Lehr, et al.
Selective Binding and Oligomerization of the Murine Granulocyte Colony-stimulating Factor Receptor by a Low Molecular Weight, Nonpeptidyl Ligand
J. Biol. Chem.,
March 7, 2003;
278(11):
9426 - 9434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Bennett, J. P. Kanki, J. Rhodes, T. X. Liu, B. H. Paw, M. W. Kieran, D. M. Langenau, A. Delahaye-Brown, L. I. Zon, M. D. Fleming, et al.
Myelopoiesis in the zebrafish, Danio rerio
Blood,
August 1, 2001;
98(3):
643 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kawakami, J. Taguchi, T. Murata, and R. K. Puri
The interleukin-13 receptor {alpha}2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway
Blood,
May 1, 2001;
97(9):
2673 - 2679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Lakshman and A Finn
Neutrophil disorders and their management
J. Clin. Pathol.,
January 1, 2001;
54(1):
7 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Freedman, M. A. Bonilla, C. Fier, A. A. Bolyard, D. Scarlata, L. A. Boxer, S. Brown, B. Cham, G. Kannourakis, S. E. Kinsey, et al.
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
Blood,
July 15, 2000;
96(2):
429 - 436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. White, M. H. Alarcon, and D. J. Tweardy
Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform
Blood,
June 1, 2000;
95(11):
3335 - 3340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Hunter and B. R. Avalos
Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival
Blood,
March 15, 2000;
95(6):
2132 - 2137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dong and A. C. Larner
Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the janus kinases
Blood,
March 1, 2000;
95(5):
1656 - 1662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Ward, I. Touw, and A. Yoshimura
The Jak-Stat pathway in normal and perturbed hematopoiesis
Blood,
January 1, 2000;
95(1):
19 - 29.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Moliterno and J. L. Spivak
Posttranslational Processing of the Thrombopoietin Receptor Is Impaired in Polycythemia Vera
Blood,
October 15, 1999;
94(8):
2555 - 2561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Ward, L. Smith, J. P. de Koning, Y. van Aesch, and I. P. Touw
Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells
J. Biol. Chem.,
May 21, 1999;
274(21):
14956 - 14962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-Q. Li and M. Horwitz
Characterization of Mutant Neutrophil Elastase in Severe Congenital Neutropenia
J. Biol. Chem.,
April 20, 2001;
276(17):
14230 - 14241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kawakami, F. Takeshita, and R. K. Puri
Identification of Distinct Roles for a Dileucine and a Tyrosine Internalization Motif in the Interleukin (IL)-13 Binding Component IL-13 Receptor alpha 2 Chain
J. Biol. Chem.,
June 29, 2001;
276(27):
25114 - 25120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Kroll, D. Barth-Baus, and J. O. Hensold
The Carboxyl-terminal Domain of the Granulocyte Colony-stimulating Factor Receptor Uncouples Ribosomal Biogenesis from Cell Cycle Progression in Differentiating 32D Myeloid Cells
J. Biol. Chem.,
December 21, 2001;
276(52):
49410 - 49418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Verdier, P. Walrafen, N. Hubert, S. Chretien, S. Gisselbrecht, C. Lacombe, and P. Mayeux
Proteasomes Regulate the Duration of Erythropoietin Receptor Activation by Controlling Down-regulation of Cell Surface Receptors
J. Biol. Chem.,
June 9, 2000;
275(24):
18375 - 18381.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|